Celcuity (CELC) Other Operating Expenses (2025)
Celcuity's (CELC) quarterly Other Operating Expenses came in at -$5000.0 in Q4 2025.
Powered by 
Analysis
Celcuity (CELC) Other Operating Expenses (2025) Analysis & Trends
Celcuity (CELC) has 1 years of Other Operating Expenses data on file, last reported at -$5000.0 in Q4 2025.
- Quarterly Other Operating Expenses changed N/A year-over-year to -$5000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5000.0 (changed N/A YoY) and the FY2025 annual result came in at -$5000.0, changed N/A from the prior year.
- Other Operating Expenses was little changed at -$5000.0 in Q4 2025.
- In the past five years, Other Operating Expenses ranged from a high of -$5000.0 in Q4 2025 to a low of -$5000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Celcuity | 5.19 Bn | 5.19 Bn | - |